Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer.
暂无分享，去创建一个
S. Darb-Esfahani | W. Schmitt | M. Dragomir | J. Sehouli | H. Kulbe | I. Braicu | P. Bischoff | B. Sinn | E. Taube | Sofya Marchenko | Inga Hoffmann | Nanna Monjé | S. Schallenberg | Carlotta Keunecke | D. Horst | C. A. Kunze | Paul Jank | Carsten Denkert | Christine Sers